Project Details
Description
An International Phase 3 Randomized Trial of Autologus Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/12 → 11/30/18 |
Funding
- ARGOS THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.